Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2

Molecular and Cellular Biology

Volumn 22, Issue 1, 2002, Pages 270-285

  Esparis Ogando A ^a   Diaz Rodriguez E ^a   Montero, J C ^a   Yuste, L ^a   Crespo, P ^a   Pandiella, A ^a  

^a Instituto de Biología Funcional y Genómica and Departamento de Microbiología y Genética   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETROVIRUS; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BUTADIENES; CELL DIVISION; ENZYME INHIBITORS; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 7; MITOGEN-ACTIVATED PROTEIN KINASES; NEUREGULINS; NITRILES; PHOSPHORYLATION; PHTHALIMIDES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0036133133     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.1.270-285.2002     Document Type: Article

References (77)

1. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase
2. C-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1
3. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors
4. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor
5. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display
6. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase
7. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system
8. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
9. 4,5-Dianilinophthalimide: A protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity
10. Neuregulins and their receptors: A versatile signalling module in organogenesis and oncogenesis
11. TrkA receptor ectodomain cleavage generates a tyrosine- phoshorylated cell-associated fragment
12. Mammalian MAP kinase signalling cascades
13. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway
14. Multiple mitogenactivated protein kinase signaling pathways connect the Cot oncoprotein to the c-jun promoter and to cellular transformation
15. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway
16. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells
17. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: Role of PI3 kinase and p38 MAP kinase pathways
18. Take your partners, please-signal diversification by the erbB family of receptor tyrosine kinases
19. Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases
20. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control
21. Signalling-competent truncated forms of ErbB2 in breast cancer cells: Differential regulation by protein kinase C and phosphatidylinositol 3-kinase
22. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
23. Inhibition of the MAP kinase cascade blocks heregulininduced cell cycle progression in T-47D human breast cancer cells
24. Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Gαq and Gα12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel ras and rho-independent pathway
25. Organization and regulation of mitogen-activated protein kinase signaling pathways
26. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus
27. ErbB kinases and NDF signaling in human prostate cancer cells
28. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
29. C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes
30. Cell growth control by G protein-coupled receptors: From signal transduction to signal integration
31. erbB3 possesses an impaired tyrosine kinase activity
32. Regulatory role of MEF2D in serum induction of the c-jun promoter
33. erbB2
34. The torso receptor tyrosine kinase can activate Raf in a Ras-independent pathway
35. The biology of erbB-2/neu/HER2 and its role in cancer
36. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development
37. Binding interaction of the heregulinβ egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis
38. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus
39. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
40. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor
41. Ras-dependent growth factor regulation of MEK kinase in PC12 cells
42. Primary structure of BMK1: A new mammalian map kinase
43. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts
44. 2-terminal kinase, p38s, and extracellular signal-regulated kinase 5
45. How do small GTPase signal transduction pathways regulate cell cycle entry?
46. Small GTPases and cell cycle regulation
47. Membrane-anchored growth factors
48. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK
49. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner
50. Isolation of the Neu/HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
51. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations
52. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network
53. Specificity within the EGF family/ErbB receptor family signaling network
54. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor
55. Mitogen-activated protein kinase pathways
56. c-neu density govern receptor interactions and tyrosine kinase activation
57. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
58. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel and atypical protein kinase C isotypes
59. Understanding Ras: 'It ain't over 'til it's over'
60. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor
61. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer
62. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
63. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
64. Bivalence of EGF-like ligands drives the ErbB signaling network
65. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: From orphanhood to multiple stromal ligands
66. Signal transduction by receptors with tyrosine kinase activity
67. Receptor protein tyrosine kinases and their signal transduction pathways
68. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3
69. Mitogenactivated protein kinase: Conservation of a three-kinase module from yeast to human
70. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes
71. Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains
72. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium
73. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogenactivated protein kinase, ERK5/BMK1
74. Active MAP kinase in mitosis: Localization at kinetochores and association with the motor protein CENP-E
75. Components of a new human protein kinase signal transduction pathway
76. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit